{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:54:49Z","timestamp":1757613289648,"version":"3.44.0"},"reference-count":185,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128200162"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/b978-0-12-820016-2.00012-4","type":"book-chapter","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T05:38:08Z","timestamp":1584077888000},"page":"269-298","source":"Crossref","is-referenced-by-count":0,"title":["A new approach for cancer treatment: from specific induction of breast cancer to innovative gold-nanoparticle mediated thermal therapies"],"prefix":"10.1016","author":[{"given":"Eduardo","family":"Costa","sequence":"first","affiliation":[]},{"given":"Alexandra","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"A. Silv\u00e9rio","family":"Cabrita","sequence":"additional","affiliation":[]},{"given":"Catarina P.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Isabel V.","family":"Figueiredo","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J. Clin."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nrc2013","article-title":"Cancer as an evolutionary and ecological process","volume":"6","author":"Merlo","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib3","first-page":"217","article-title":"Chronic inflammation and cancer","volume":"16","author":"Shacter","year":"2002","journal-title":"Oncology (Williston Park)"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"3","key":"10.1016\/B978-0-12-820016-2.00012-4_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1040-8428(97)00232-1","article-title":"Chemo\u1e55revention of human cancer: biology and therapy","volume":"25","author":"Tanaka","year":"1997","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib6","first-page":"1","article-title":"Understanding carcinogenesis for fighting oral cancer","volume":"2011","author":"Tanaka","year":"2011","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib7","first-page":"1","article-title":"Pathobiology and chemoprevention of bladder cancer","volume":"2011","author":"Tanaka","year":"2011","journal-title":"J.\u00a0Oncol."},{"issue":"6127","key":"10.1016\/B978-0-12-820016-2.00012-4_bib8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib9","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1093\/hmg\/ddi114","article-title":"Epigenetic reprogramming in mammals","volume":"14","author":"Morgan","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2011.08.008","article-title":"Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification","volume":"146","author":"Tan","year":"2011","journal-title":"Cell"},{"issue":"10","key":"10.1016\/B978-0-12-820016-2.00012-4_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A\u00a0decade of exploring the cancer epigenome \u2014 biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc1279","article-title":"The history of cancer epigenetics","volume":"4","author":"Feinberg","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"6127","key":"10.1016\/B978-0-12-820016-2.00012-4_bib14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1126\/science.1230184","article-title":"Epigenetic reprogramming in cancer","volume":"339","author":"Suv\u00e0","year":"2013","journal-title":"Science"},{"issue":"5895","key":"10.1016\/B978-0-12-820016-2.00012-4_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation distinguishes genes of some human cancers from their normal counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"issue":"19","key":"10.1016\/B978-0-12-820016-2.00012-4_bib16","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1093\/nar\/11.19.6883","article-title":"The 5-methylcytosine content of DNA from human tumors","volume":"11","author":"Gama-Sosa","year":"1983","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2013.03.008","article-title":"Interplay between the cancer genome and epigenome","volume":"153","author":"Shen","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.biochem.78.070907.103946","article-title":"Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases","volume":"79","author":"Mosammaparast","year":"2010","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib21","first-page":"1","article-title":"DNA methylation profiles in cancer diagnosis and therapeutics","author":"Pan","year":"2017","journal-title":"Clin. Exp. Med."},{"issue":"7","key":"10.1016\/B978-0-12-820016-2.00012-4_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/B978-0-12-820016-2.00012-4_bib23","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.21873\/anticanres.10998","article-title":"Assessment of promoter methylation identifies PTCH as a putative tumor-suppressor gene in human CLL","volume":"36","author":"Schmidt-Wolf","year":"2016","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib24","doi-asserted-by":"crossref","first-page":"26591","DOI":"10.1038\/srep26591","article-title":"Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/B978-0-12-820016-2.00012-4_bib25","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1007\/s13277-016-5278-5","article-title":"Biomarkers of genome instability and cancer epigenetics","volume":"37","author":"Reis","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.trsl.2011.11.005","article-title":"Canine tumors: a spontaneous animal model of human carcinogenesis","author":"Pinho","year":"2012","journal-title":"Transl. Res."},{"issue":"9","key":"10.1016\/B978-0-12-820016-2.00012-4_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1289\/ehp.96104938","article-title":"Mammary gland neoplasia in long-term rodent studies","volume":"104","author":"Russo","year":"1996","journal-title":"Environ. Health Perspect."},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0955-0674(00)00283-0","article-title":"Building \u201cvalidated\u201d mouse models of human cancer","volume":"13","author":"Hann","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6 Suppl. l","key":"10.1016\/B978-0-12-820016-2.00012-4_bib29","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1177\/0192623312454242","article-title":"Proliferative and nonproliferative lesions of the rat and mouse mammary, Zymbal's, preputial, and clitoral glands","volume":"40","author":"Rudmann","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ddmod.2005.05.008","article-title":"Models of breast cancer","volume":"2","author":"Matulka","year":"2005","journal-title":"Drug Discov. Today Dis. Model."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/bcr645","article-title":"Models of breast cancer: is merging human and animal models the future?","volume":"6","author":"Kim","year":"2004","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/bcr723","article-title":"Models of breast cancer: quo vadis, animal modeling?","volume":"6","author":"Wagner","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib33","article-title":"Proliferative lesions of the mammary gland in rats","author":"Mann","year":"1996","journal-title":"Guid. Toxicol. Pathol. Soc. Toxicol. Pathol. Regist. Pathol. Forces Inst. Pathol."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib34","first-page":"285","article-title":"Benign and malignant mammary tumors induced by DMBA in female Wistar rats","volume":"20","author":"Dias","year":"1999","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib35","first-page":"91","article-title":"Histopathology of mammary tumours in female rats treated with 1-methyl-1-nitrosourea","volume":"34","author":"Liska","year":"2000","journal-title":"Endocr. Regul."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib36","doi-asserted-by":"crossref","DOI":"10.1023\/A:1009582012493","article-title":"Rat models of premalignant breast disease","volume":"5","author":"Thompson","year":"2000","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib37","series-title":"Methods in Mammary Gland Biology and Breast Cancer Research","article-title":"A\u00a0comparison of the salient features of mouse, rat, and human mammary tumorigenesis","author":"Medina","year":"2000"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib38","doi-asserted-by":"crossref","DOI":"10.1046\/j.1524-4741.2000.98071.x","article-title":"Chemoprevention of DMBA-induced mammary tumors in rats by a combined regimen of alpha-tocopherol, selenium, and ascorbic Acid","volume":"6","author":"Dias","year":"2000","journal-title":"Breast J."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-013-2699-3","article-title":"The molecular diversity of Luminal A breast tumors","volume":"141","author":"Ciriello","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-151","article-title":"Genetic heterogeneity in breast cancer: the road to personalized medicine?","volume":"11","author":"Baird","year":"2013","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib41","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ctrv.2011.11.005","article-title":"Molecular biology in breast cancer: intrinsic subtypes and signaling pathways","volume":"38","author":"Eroles","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejcsup.2013.07.027","article-title":"The role of the pathologist in the decision-making process","volume":"11","author":"Paolo","year":"2013","journal-title":"EJC Suppl."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10911-011-9202-8","article-title":"The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling","volume":"16","author":"Molyneux","year":"2011","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib44","doi-asserted-by":"crossref","first-page":"a003293","DOI":"10.1101\/cshperspect.a003293","article-title":"Systems biology and genomics of breast cancer","volume":"3","author":"Perou","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/B978-0-12-820016-2.00012-4_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3816\/CBC.2010.n.026","article-title":"Through a glass darkly: advances in understanding breast cancer biology, 2000\u20132010","volume":"10","author":"Carey","year":"2010","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10549-013-2743-3","article-title":"Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes","volume":"142","author":"Prat","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"16","key":"10.1016\/B978-0-12-820016-2.00012-4_bib47","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.7150\/jca.18457","article-title":"Breast cancer cell line classification and its relevance with breast tumor subtyping","volume":"8","author":"Dai","year":"2017","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib48","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3889\/oamjms.2018.231","article-title":"Presentation of the molecular subtypes of breast cancer detected by immunohistochemistry in surgically treated patients","volume":"6","author":"Kondov","year":"2018","journal-title":"Open Access Maced. J. Med. Sci."},{"issue":"10","key":"10.1016\/B978-0-12-820016-2.00012-4_bib50","first-page":"2929","article-title":"Breast cancer intrinsic subtype classification, clinical use and future trends","volume":"5","author":"Dai","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib51","first-page":"854","article-title":"Taxonomy of breast cancer based on normal cell phenotype predicts outcome","volume":"124","author":"Santagata","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib52","first-page":"1","article-title":"One medicine: an introduction","volume":"28","author":"Gardner","year":"2008","journal-title":"Breast Dis."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/BD-2007-28104","article-title":"Special considerations in mouse models of breast cancer","volume":"28","author":"Borowsky","year":"2007","journal-title":"Breast Dis."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3835(94)03672-6","article-title":"Comparative pathology of mammary tumorigenesis in transgenic mice","volume":"90","author":"Cardiff","year":"1995","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib55","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003111","article-title":"A\u00a0compendium of the mouse mammary tumor biologist: from the initial observations in the house mouse to the development of genetically engineered mice","volume":"3","author":"Cardiff","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib56","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2007-8-5-r76","article-title":"Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors","volume":"8","author":"Herschkowitz","year":"2007","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5625\/lar.2018.34.4.160","article-title":"Mouse models of breast cancer in preclinical research","volume":"34","author":"Park","year":"2018","journal-title":"Lab. Anim. Res."},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib58","first-page":"6233","article-title":"Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib59","doi-asserted-by":"crossref","first-page":"e00389","DOI":"10.1042\/BSR20160053","article-title":"Silencing of SOX12 by shRNA suppresses migration, invasion and proliferation of breast cancer cells","volume":"36","author":"Ding","year":"2016","journal-title":"Biosci. Rep."},{"issue":"11","key":"10.1016\/B978-0-12-820016-2.00012-4_bib60","doi-asserted-by":"crossref","first-page":"e112720","DOI":"10.1371\/journal.pone.0112720","article-title":"Diallyl disulfide suppresses SRC\/Ras\/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/B978-0-12-820016-2.00012-4_bib61","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1158\/1535-7163.MCT-14-0243","article-title":"miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer","volume":"13","author":"Tang","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2889","article-title":"Choosing the right cell line for breast cancer research","volume":"13","author":"Holliday","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib63","doi-asserted-by":"crossref","DOI":"10.1023\/A:1006326203858","article-title":"Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic","volume":"17","author":"Hoffman","year":"1999","journal-title":"Invest. New Drugs"},{"issue":"3","key":"10.1016\/B978-0-12-820016-2.00012-4_bib64","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2010.03.070","article-title":"Mouse models for breast cancer metastasis","volume":"394","author":"Kim","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib65","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/1535-7163.MCT-14-0945","article-title":"Effective targeting of estrogen receptor-negative breast cancers with the protein Kinase D inhibitor CRT0066101","volume":"14","author":"Borges","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1158\/1078-0432.CCR-08-0897","article-title":"Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor models","volume":"15","author":"Zhang","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib67","article-title":"Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor1","volume":"52","author":"Aslakson","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib68","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr3599","article-title":"Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide","volume":"16","author":"Cochrane","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/B978-0-12-820016-2.00012-4_bib69","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1158\/0008-5472.CAN-10-3074","article-title":"Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer","volume":"71","author":"Cerliani","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13058-015-0523-1","article-title":"Patient-derived xenograft models of breast cancer and their predictive power","volume":"17","author":"Whittle","year":"2015","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.14348\/molcells.2016.2350","article-title":"An integrative approach to precision cancer medicine using patient-derived xenografts","volume":"39","author":"Cho","year":"2016","journal-title":"Mol. Cells"},{"issue":"8","key":"10.1016\/B978-0-12-820016-2.00012-4_bib72","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrc3972","article-title":"Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts","volume":"15","author":"Hoffman","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/B978-0-12-820016-2.00012-4_bib73","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/B978-0-12-820016-2.00012-4_bib74","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/B978-0-12-820016-2.00012-4_bib75","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-12-2408","article-title":"The Promise of patient-derived xenografts: the best laid plans of mice and men","volume":"18","author":"Kopetz","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bcp.2014.06.008","article-title":"Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology","volume":"91","author":"Rosfjord","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1517\/17425255.2015.983073","article-title":"Animal models for exploring the pharmacokinetics of breast cancer therapies","volume":"11","author":"Rashid","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib78","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cam4.94","article-title":"Curcumin improves the therapeutic efficacy of Listeria at - Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1","volume":"2","author":"Singh","year":"2013","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/B978-0-12-820016-2.00012-4_bib79","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/cas.12685","article-title":"Mammary tissue microenvironment determines T cell-dependent breast cancer-associated inflammation","volume":"106","author":"Takahashi","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib80","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-2407-8-228","article-title":"Imagable 4T1 model for the study of late stage breast cancer","volume":"8","author":"Tao","year":"2008","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib81","doi-asserted-by":"crossref","first-page":"e21106","DOI":"10.1371\/journal.pone.0021106","article-title":"M402, a novel Heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib82","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1586\/erm.09.31","article-title":"MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer","volume":"9","author":"Taneja","year":"2009","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"13","key":"10.1016\/B978-0-12-820016-2.00012-4_bib83","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.ejca.2004.05.013","article-title":"Forty years of cancer modelling in the mouse","volume":"40","author":"Hirst","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01806074","article-title":"Experimentally induced mammary tumors in rats","volume":"39","author":"Russo","year":"1996","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib85","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3233\/BD-2007-28109","article-title":"Toxicogenomic analyses of genetic susceptibility to mammary gland carcinogenesis in rodents: implications for human breast cancer","volume":"28","author":"Zarbl","year":"2007","journal-title":"Breast Dis."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/BD-2007-28108","article-title":"The rat oncogenome: comparative genetics and genomics of rat models of mammary carcinogenesis","volume":"28","author":"Shull","year":"2007","journal-title":"Breast Dis."},{"issue":"1\u20132","key":"10.1016\/B978-0-12-820016-2.00012-4_bib87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0027-5107(95)00129-8","article-title":"Animal models for breast cancer","volume":"333","author":"Sukumar","year":"1995","journal-title":"Mutat. Res. Fund. Mol. Mech. Mutagen."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib88","first-page":"9","article-title":"Influence of strain and sex on the local development of mammary tumors induced by direct application of DMBA powder to rat mammary glands","volume":"40","author":"Tsubura","year":"1990","journal-title":"Acta Pathol. Jpn."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib89","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.etp.2010.09.005","article-title":"Mammary gland proliferation in female rats: effects of the estrous cycle, pseudo-pregnancy and age","volume":"64","author":"Hvid","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib90","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/bcr20","article-title":"Mouse models for breast cancer","volume":"2","author":"Hennighausen","year":"2000","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib91","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.canlet.2005.04.025","article-title":"Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats","volume":"235","author":"Cos","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/BD-2007-28107","article-title":"Chemical carcinogenesis of rat and mouse mammary glands","volume":"28","author":"Medina","year":"2007","journal-title":"Breast Dis."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib93","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/01926230500352226","article-title":"Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors","volume":"33","author":"Currier","year":"2005","journal-title":"Toxicol. Pathol."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib94","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1026499523505","article-title":"An atlas of mouse mammary gland development","volume":"5","author":"Richert","year":"2000","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib95","doi-asserted-by":"crossref","DOI":"10.1023\/A:1026491221687","article-title":"A\u00a0developmental atlas of rat mammary gland histology","volume":"5","author":"Masso-Welch","year":"2000","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib96","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr1368","article-title":"Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis","volume":"8","author":"Sternlicht","year":"2006","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10911-013-9287-3","article-title":"Positional variations in mammary gland development and cancer","volume":"18","author":"Veltmaat","year":"2013","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"issue":"10","key":"10.1016\/B978-0-12-820016-2.00012-4_bib98","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.fct.2007.03.020","article-title":"Effect of milk on the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor model in rat","volume":"45","author":"Zhou","year":"2007","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2012.04.021","article-title":"CYP1B1 and hormone-induced cancer","volume":"324","author":"Gajjar","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib100","first-page":"1","article-title":"Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures","volume":"92","author":"IARC","year":"2010","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"year":"2000","series-title":"The Cell: A Molecular Approach","author":"GM","key":"10.1016\/B978-0-12-820016-2.00012-4_bib101"},{"issue":"8","key":"10.1016\/B978-0-12-820016-2.00012-4_bib102","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/carcin\/5.8.1021","article-title":"7,12-dimethylbenz[a]anthracene-DNA adducts in sprague-dawley and long-evans female rats: the relationship of DNA adducts to mammary cancer","volume":"5","author":"Daniel","year":"1984","journal-title":"Carcinogenesis"},{"issue":"2\u20133","key":"10.1016\/B978-0-12-820016-2.00012-4_bib103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.etp.2006.05.003","article-title":"Characterisation of two rat mammary tumour models for breast cancer research by gene expression profiling","volume":"58","author":"Marxfeld","year":"2006","journal-title":"Exp. Toxicol. Pathol."},{"issue":"7","key":"10.1016\/B978-0-12-820016-2.00012-4_bib104","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1080\/01926230500437027","article-title":"Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas","volume":"33","author":"Liang","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib105","doi-asserted-by":"crossref","DOI":"10.1023\/A:1026443305758","article-title":"Atlas and histologic classification of tumors of the rat mammary gland","volume":"5","author":"Russo","year":"2000","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"issue":"8","key":"10.1016\/B978-0-12-820016-2.00012-4_bib106","doi-asserted-by":"crossref","first-page":"915","DOI":"10.5858\/2002-126-0915-HCOMNL","article-title":"Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with human breast tumors","volume":"126","author":"Costa","year":"2002","journal-title":"Arch. Pathol. Lab Med."},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib107","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1590\/S0041-87812004000500006","article-title":"Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene","volume":"59","author":"Barros","year":"2004","journal-title":"Rev. Hosp. Clin. Fac. Med. Sao. Paulo."},{"year":"2003","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs","author":"Tavassoli","key":"10.1016\/B978-0-12-820016-2.00012-4_bib108"},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib109","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1097-0029(20010115)52:2<224::AID-JEMT1007>3.0.CO;2-A","article-title":"Validity of mouse mammary tumour models for human breast cancer: comparative pathology","volume":"52","author":"Cardiff","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib110","doi-asserted-by":"crossref","DOI":"10.1023\/A:1018712905244","article-title":"The comparative pathology of human and mouse mammary glands","volume":"4","author":"Cardiff","year":"1999","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"issue":"8","key":"10.1016\/B978-0-12-820016-2.00012-4_bib111","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.onc.1203277","article-title":"The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting","volume":"19","author":"Cardiff","year":"2000","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib112","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.etp.2013.09.001","article-title":"Improving discrimination in the grading of rat mammary tumors using two-dimensional mapping of histopathological observations","volume":"66","author":"Lopes","year":"2014","journal-title":"Exp. Toxicol. Pathol."},{"issue":"19","key":"10.1016\/B978-0-12-820016-2.00012-4_bib113","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","article-title":"Mechanisms of endocrine resistance in breast cancer","volume":"62","author":"Osborne","year":"2011","journal-title":"Annu. Rev. Med."},{"issue":"8","key":"10.1016\/B978-0-12-820016-2.00012-4_bib115","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and Docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib116","first-page":"21","article-title":"Mechanisms behind the resistance to trastuzumab in HER2-amplified breast cancer and strategies to overcome it","volume":"10","author":"Luque-Cabal","year":"2016","journal-title":"Clin. Med. Insights Oncol."},{"issue":"12","key":"10.1016\/B978-0-12-820016-2.00012-4_bib117","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4155\/fmc.15.93","article-title":"Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies","volume":"7","author":"Review","year":"2015","journal-title":"Future Med. Chem."},{"issue":"9","key":"10.1016\/B978-0-12-820016-2.00012-4_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092193","article-title":"Targeting breast cancer stem cells to overcome treatment resistance","volume":"23","author":"Palomeras","year":"2018","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib119","first-page":"920","article-title":"Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status","volume":"24","author":"Bertaut","year":"2015","journal-title":"Eur. J. Cancer Care"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2008.19.9844","article-title":"Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review","volume":"28","author":"Dawood","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib121","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus Docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib122","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: a looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"6797","key":"10.1016\/B978-0-12-820016-2.00012-4_bib123","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"7403","key":"10.1016\/B978-0-12-820016-2.00012-4_bib124","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"issue":"7418","key":"10.1016\/B978-0-12-820016-2.00012-4_bib125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib126","first-page":"230","article-title":"Advances in novel drug delivery strategies for breast cancer therapy. Artif cells, blood substitutes","volume":"38","author":"Dhankhar","year":"2010","journal-title":"Biotechnology"},{"issue":"10","key":"10.1016\/B978-0-12-820016-2.00012-4_bib127","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamasurg.2013.3393","article-title":"Breast cancer: a review for the general surgeon","volume":"148","author":"Matsen","year":"2013","journal-title":"JAMA Surg."},{"issue":"3","key":"10.1016\/B978-0-12-820016-2.00012-4_bib128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0019-509X.104486","article-title":"Breast cancer management: past, present and evolving","volume":"49","author":"Akram","year":"2012","journal-title":"Indian J. Cancer"},{"issue":"Suppl. 5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib129","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Senkus","year":"2015","journal-title":"Ann. Oncol."},{"issue":"9869","key":"10.1016\/B978-0-12-820016-2.00012-4_bib130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"issue":"9814","key":"10.1016\/B978-0-12-820016-2.00012-4_bib131","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","author":"Albain","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib132","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/GCO.0b013e3283414e87","article-title":"HER2-Positive breast cancer: current management of early, advanced, and recurrent disease","volume":"23","author":"Callahan","year":"2011","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"24","key":"10.1016\/B978-0-12-820016-2.00012-4_bib133","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1200\/JCO.2015.60.8620","article-title":"Efficacy of adjuvant trastuzumab for patients with human epidermal growth factor receptor 2-positive early breast cancer and tumors 2\u00a0cm: a meta-analysis of the randomized trastuzumab trials","volume":"33","author":"O\u2019sullivan","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib134","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002018-200831060-00002","article-title":"Cardiotoxicity profile of trastuzumab","volume":"31","author":"Ewer","year":"2008","journal-title":"Drug Saf."},{"issue":"7","key":"10.1016\/B978-0-12-820016-2.00012-4_bib135","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S1470-2045(15)00079-0","article-title":"Continued value of adjuvant anthracyclines as treatment for early breast cancer","volume":"16","author":"Turner","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib136","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/bjc.2011.516","article-title":"Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer","volume":"106","author":"Tsang","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/B978-0-12-820016-2.00012-4_bib137","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1634\/theoncologist.2014-0033","article-title":"Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA","volume":"19","author":"Swain","year":"2014","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib138","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7150\/ijms.17288","article-title":"Radiation therapy and cancer control in developing countries: can we save more lives?","volume":"14","author":"Baskar","year":"2017","journal-title":"Int. J. Med. Sci."},{"issue":"10074","key":"10.1016\/B978-0-12-820016-2.00012-4_bib139","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/B978-0-12-800685-6.00010-2","article-title":"Breast cancer","volume":"389","author":"Marcom","year":"2017","journal-title":"Genom. Precis. Med. Prim. Care Third Ed"},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib140","first-page":"1","article-title":"Introduction of nanotechnology in herbal drugs and nutraceutical: a review","volume":"6","author":"Gopi","year":"2016","journal-title":"J.\u00a0Nanomed. Biother. Discov."},{"issue":"8","key":"10.1016\/B978-0-12-820016-2.00012-4_bib141","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2174\/1567201813666160713121122","article-title":"Nanoparticles for cancer targeting: current and future directions","volume":"13","author":"Swain","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib142","first-page":"1","volume":"vol. 166","author":"Mirkin","year":"2015"},{"issue":"3","key":"10.1016\/B978-0-12-820016-2.00012-4_bib143","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/1061186X.2015.1051049","article-title":"Nanocarriers for cancer-targeted drug delivery","volume":"24","author":"Kumari","year":"2016","journal-title":"J.\u00a0Drug Target."},{"issue":"12","key":"10.1016\/B978-0-12-820016-2.00012-4_bib144","first-page":"3039","article-title":"Transport of molecules in the tumor interstitium: a review","volume":"47","author":"Jain","year":"1987","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pon.1245","article-title":"Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review","volume":"17","author":"Lemieux","year":"2008","journal-title":"Psycho Oncol."},{"issue":"7","key":"10.1016\/B978-0-12-820016-2.00012-4_bib146","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.xphs.2016.03.019","article-title":"An overview of pharmaceutical excipients: safe or not safe?","volume":"105","author":"Abrantes","year":"2016","journal-title":"J.\u00a0Pharm. Sci."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib147","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/17435390802398309","article-title":"Toxicological assessment of orally delivered nanoparticulate insulin","volume":"2","author":"Reis","year":"2008","journal-title":"Nanotoxicology"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib148","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.2147\/IJN.S148359","article-title":"Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy","volume":"12","author":"Zhang","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib149","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2016.05.033","article-title":"Orchestrating immune responses: how size, shape and rigidity affect the immunogenicity of particulate vaccines","volume":"234","author":"Benne","year":"2016","journal-title":"J.\u00a0Control. Release"},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib151","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nantod.2011.02.003","article-title":"Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies","volume":"6","author":"Iversen","year":"2011","journal-title":"Nano Today"},{"issue":"7","key":"10.1016\/B978-0-12-820016-2.00012-4_bib152","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1039\/c2cs15309b","article-title":"Endocytosis at the nanoscale","volume":"41","author":"Canton","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib153","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-3155-12-5","article-title":"Engineered nanoparticles interacting with cells: size matters","volume":"12","author":"Shang","year":"2014","journal-title":"J.\u00a0Nanobiotechnol."},{"issue":"3","key":"10.1016\/B978-0-12-820016-2.00012-4_bib154","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jat.1486","article-title":"Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres","volume":"30","author":"Arnida","year":"2010","journal-title":"J.\u00a0Appl. Toxicol."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib155","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/nl052396o","article-title":"Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells","volume":"6","author":"Chithrani","year":"2006","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib156","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/smll.201001832","article-title":"Polymorph- and size-dependent uptake and toxicity of TiO2 nanoparticles in living lung epithelial cells","volume":"7","author":"Andersson","year":"2011","journal-title":"Small"},{"issue":"12","key":"10.1016\/B978-0-12-820016-2.00012-4_bib157","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/smll.200900005","article-title":"Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles","volume":"5","author":"Lu","year":"2009","journal-title":"Small"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib158","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-3155-10-39","article-title":"Quantifying size-dependent interactions between fluorescently labeled polystyrene nanoparticles and mammalian cells","volume":"10","author":"Varela","year":"2012","journal-title":"J.\u00a0Nanobiotechnol."},{"issue":"12","key":"10.1016\/B978-0-12-820016-2.00012-4_bib159","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1021\/nn101643u","article-title":"Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles","volume":"4","author":"Huang","year":"2010","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jare.2010.02.002","article-title":"Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy","volume":"1","author":"Huang","year":"2010","journal-title":"J.\u00a0Adv. Res."},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib161","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-60761-609-2_3","article-title":"Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting","author":"Greish","year":"2010"},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib162","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0006-3495(01)76144-9","article-title":"Particle diameter influences adhesion under flow","volume":"80","author":"Shinde Patil","year":"2001","journal-title":"Biophys. J."},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib163","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1023\/A:1011032328064","article-title":"Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa","volume":"18","author":"Lamprecht","year":"2001","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib164","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bbagen.2017.02.007","article-title":"Structure and function of Vibrio cholerae accessory cholera enterotoxin in presence of gold nanoparticles: dependence on morphology","volume":"1861","author":"Chatterjee","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"2","key":"10.1016\/B978-0-12-820016-2.00012-4_bib165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/B978-0-12-820016-2.00012-4_bib166","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nnano.2007.88","article-title":"Nanomedicine: nanocarriers shape up for long life","volume":"2","author":"Nishiyama","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib167","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/smll.201101422","article-title":"Interactions of human endothelial cells with gold nanoparticles of different morphologies","volume":"8","author":"Bartczak","year":"2012","journal-title":"Small"},{"issue":"11","key":"10.1016\/B978-0-12-820016-2.00012-4_bib168","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.biomaterials.2010.12.057","article-title":"Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity","volume":"32","author":"Pittella","year":"2011","journal-title":"Biomaterials"},{"issue":"33","key":"10.1016\/B978-0-12-820016-2.00012-4_bib169","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1039\/C5TB00912J","article-title":"Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in\u00a0vitro gene delivery to breast cancer cells","volume":"3","author":"Tang","year":"2015","journal-title":"J.\u00a0Mater. Chem. B"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1166\/jbn.2010.1098","article-title":"Exposure, uptake, distribution and toxicity of nanomaterials in humans","volume":"6","author":"Holgate","year":"2010","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"issue":"10\u201311","key":"10.1016\/B978-0-12-820016-2.00012-4_bib171","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ultramic.2007.02.036","article-title":"Adhesive interaction measured between AFM probe and lung epithelial type II cells","volume":"107","author":"Leonenko","year":"2007","journal-title":"Ultramicroscopy"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib172","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acs.accounts.9b00103","article-title":"Nano\u2212Cell interactions of non-cationic bionanomaterials","volume":"52","author":"Wai","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"9\u201310","key":"10.1016\/B978-0-12-820016-2.00012-4_bib173","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/smll.201201229","article-title":"Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions","volume":"9","author":"Pelaz","year":"2013","journal-title":"Small"},{"issue":"1","key":"10.1016\/B978-0-12-820016-2.00012-4_bib174","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7326\/M15-2722","article-title":"Evaluating hepatitis B virus reactivation during solid tumor chemotherapy: evidence to Guide pretreatment hepatitis B screening and prophylaxis","volume":"164","author":"Lo Re","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/B978-0-12-820016-2.00012-4_bib175","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/molecules22091445","article-title":"Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications","volume":"22","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/B978-0-12-820016-2.00012-4_bib176","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cjoc.201500839","article-title":"DNA nanotechnology mediated gold nanoparticle conjugates and their applications in biomedicine","volume":"34","author":"Wang","year":"2016","journal-title":"Chin. J. Chem."},{"issue":"5601","key":"10.1016\/B978-0-12-820016-2.00012-4_bib177","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1126\/science.1077229","article-title":"Shape-controlled synthesis of gold and silver nanoparticles","volume":"298","author":"Sun","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/B978-0-12-820016-2.00012-4_bib178","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s12274-014-0697-3","article-title":"How toxic are gold nanoparticles? The state-of-the-art","volume":"8","author":"Fratoddi","year":"2015","journal-title":"Nano Res."},{"issue":"939","key":"10.1016\/B978-0-12-820016-2.00012-4_bib179","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1259\/bjr\/13169882","article-title":"Gold nanoparticles: a new X-ray contrast agent","volume":"79","author":"Hainfeld","year":"2006","journal-title":"Br. J. Radiol."},{"issue":"1\u20132","key":"10.1016\/B978-0-12-820016-2.00012-4_bib180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J.\u00a0Control. Release"},{"issue":"5","key":"10.1016\/B978-0-12-820016-2.00012-4_bib181","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4155\/tde-2015-0011","article-title":"Bioproduction of gold nanoparticles for photothermal therapy","volume":"7","author":"Silva","year":"2016","journal-title":"Ther. Deliv."},{"year":"2015","series-title":"Melanoma Prevention: Challenges and Progresses in Nanotechnology for Melanoma Prevention and Treatment","author":"Silva","key":"10.1016\/B978-0-12-820016-2.00012-4_bib182"},{"issue":"10","key":"10.1016\/B978-0-12-820016-2.00012-4_bib183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0165419","article-title":"EGF functionalized polymer-coated gold nanoparticles promote EGF photostability and EGFR internalization for photothermal therapy","volume":"11","author":"Silva","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-820016-2.00012-4_bib184","doi-asserted-by":"crossref","first-page":"86566","DOI":"10.18632\/oncotarget.21243","article-title":"Near-infrared photothermal therapy using anti-EGFR-gold nanorod conjugates for triple negative breast cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"55","key":"10.1016\/B978-0-12-820016-2.00012-4_bib185","doi-asserted-by":"crossref","first-page":"55ra79","DOI":"10.1126\/scitranslmed.3001447","article-title":"Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy","volume":"2","author":"Atkinson","year":"2010","journal-title":"Sci. Transl. Med."}],"container-title":["Nanomedicines for Breast Cancer Theranostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128200162000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128200162000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T18:34:01Z","timestamp":1757010841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128200162000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128200162"],"references-count":185,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-820016-2.00012-4","relation":{},"subject":[],"published":{"date-parts":[[2020]]}}}